StockData
Telomir Pharmaceuticals, Inc. logo

Telomir Pharmaceuticals, Inc. (TELO) stock

TELONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 6/30
$0.50−0.09 (-15.90%)

Close on Nov 12, 2026Market cap $34.42MP/E –Yield –

Telomir Pharmaceuticals statistics

54 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
–
Last ex-dividend date
No dividends
Fundamentals through
Sep 30, 2026
Share price as of
Nov 12, 2026

Valuation ratiosIndustry

Market Cap
$34.42M
$280.48M
Enterprise Value
$29.90M
$148.62M
PB Ratio
7.81
2.05
P/TBV Ratio
7.81
2.29

Share statisticsIndustry

Shares Change (YoY)
62.1%
10.9%
Shares Change (QoQ)
0.00%
0.48%
Float
49M
49M
Shares Held by Insiders
28.3%
12.1%
Shares Held by Institutions
4.33%
56.4%

Short sellingIndustry

Short Interest
750,539
–
Short Interest Change
-2.53%
-0.76%
Short % of Float
1.52%
9.06%
Short % of Shares Outstanding
1.09%
6.30%
Days to Cover
11.90
5.13

Stock price statisticsIndustry

52-Week High
$1.58
–
52-Week Low
$0.47
–
20-Day Moving Average
$0.88
–
50-Day Moving Average
$1.05
–
200-Day Moving Average
$1.20
–
Average True Range (14)
$0.10
–
Price Change (1 Week)
-35.9%
1.51%
Price Change (1 Month)
-52.3%
-2.37%
Price Change (3 Months)
-54.1%
-21.1%
Price Change (6 Months)
-60.6%
-22.8%
Price Change (YTD)
-62.4%
-22.6%
Price Change (1 Year)
-64.8%
-21.0%
Average Volume (10 Days)
192,269
–
Average Volume (20 Days)
125,895
–
Average Volume (90 Days)
102,716
–
Relative Volume
2.30
0.80
Relative Strength Index (14)
12.8
44.7
Volatility (1 Year)
67.6%
80.2%
Beta (5 Years)
1.21
1.07

Returns on capitalIndustry

Return on Equity (ROE)
-96.3%
-51.3%
Return on Assets (ROA)
-91.0%
-40.7%

Financial positionIndustry

Current Ratio
19.60
3.31
Quick Ratio
19.07
2.41

EfficiencyIndustry

Profits Per Employee
-$183
-$683.67K
Employee Count
30,000
75
WACC
10.9%
10.0%

Income statement (TTM)Industry

Net Income
-$5.48M
-$21.61M
EPS (Diluted)
-$0.89
-$0.75

Balance sheetIndustry

Net Cash (Debt)
$4.52M
$16.98M
Net Cash Per Share
$0.07
$0.72
Equity (Book Value)
$4.40M
$52.68M
Book Value Per Share
$0.06
$1.50
Tangible Book Value
$4.40M
$26.74M
Working Capital
$4.40M
$78.52M

Cash flow (TTM)Industry

Operating Cash Flow
-$4.57M
-$12.27M

Dividends and yieldsIndustry

Earnings Yield
-15.9%
-21.0%

Scores and fair valueIndustry

Altman Z-Score
74.96
0.26
Piotroski F-Score
4
4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.

PeriodTELOS&P 500DifferenceTELO per yearS&P 500 per year
1 month-54.5%-2.7%−51.8 pts
3 months-54.9%-1.7%−53.2 pts
Year to date-62.4%+11.9%−74.3 pts
1 year-62.9%+12.0%−74.9 pts

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

1M TELO shares were sold short on Oct 30, 2026, down 2.5% from the previous report, or 1.52% of the shares available to trade. At recent volumes it would take 11.9 days to buy them back. Over the last 20 sessions, 42.2% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 2026750,539-2.5%63,07111.9
Oct 15, 2026769,992-6.7%192,5954.0
Sep 30, 2026825,678+6.3%99,1638.3
Sep 15, 2026777,078-5.2%39,44119.7
Aug 31, 2026819,595+0.7%57,73314.2
Aug 14, 2026813,874-15.5%50,07716.3
Jul 31, 2026963,348-1.1%142,0406.8
Jul 15, 2026974,290+2.2%52,97218.4
Jun 30, 2026953,308+1.2%189,1115.0
Jun 15, 2026942,330+2.1%93,62310.1
May 29, 2026923,133-11.4%87,67810.5
May 15, 20261,042,311+1.8%101,16010.3

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?